LBO — NORTH OAKS MEDICAL CENTER
IRR: 18.4% | MOIC: 2.33x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.4%
IRR
2.33x
MOIC
$238.4M
Entry EV
$385.1M
Exit EV
$122.6M
Equity Invested
Sources & Uses
S&UTotal · $238.4M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $92.6M | 38.8% | |
| Sub Debt | $23.1M | 9.7% | |
| Equity | $122.6M | 51.5% | |
| Enterprise Value | $231.4M | 97.1% | |
| Transaction Fees | $6.9M | 2.9% | |
| Total Uses | $238.4M | 100.0% |
Interpretation
INTAt 2.33x MOIC and 18.4% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $36.7M |
| Exit Ev | $385.1M |
| Net Debt At Exit | $99.6M |
| Equity At Exit | $285.5M |
| Equity Invested | $122.6M |
| Total Value Created | $162.8M |
| Value From Growth | $142.1M |
| Value From Multiple | $11.6M |
| Value From Deleveraging | $16.1M |